$2.22 Billion is the total value of CADIAN CAPITAL MANAGEMENT, LP's 28 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 12.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PANW | Buy | PALO ALTO NETWORKS INC | $268,620,000 | +19.1% | 1,318,316 | +41.9% | 12.11% | +37.6% |
| ZGNX | Buy | ZOGENIX INC | $156,977,000 | +114.0% | 3,285,410 | +146.4% | 7.08% | +147.2% |
| YNDX | Buy | YANDEX N V | $124,070,000 | +10.8% | 3,265,000 | +0.2% | 5.59% | +28.1% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $111,007,000 | -19.5% | 4,091,687 | +2.9% | 5.00% | -7.0% |
| RDWR | Buy | RADWARE LTDord | $107,159,000 | -4.0% | 4,333,149 | +1.4% | 4.83% | +10.9% |
| FB | Buy | FACEBOOK INCcl a | $96,500,000 | +38.8% | 500,000 | +19.9% | 4.35% | +60.4% |
| NFLX | Buy | NETFLIX INC | $64,281,000 | +104.9% | 175,000 | +98.9% | 2.90% | +136.8% |
| VRNS | Buy | VARONIS SYS INC | $61,293,000 | +104.7% | 989,553 | +97.1% | 2.76% | +136.6% |
| FTCH | Buy | FARFETCH LTDord sh cl a | $52,000,000 | +75.7% | 2,500,000 | +127.3% | 2.34% | +103.0% |
| GWRE | Buy | GUIDEWIRE SOFTWARE INC | $50,051,000 | +21.0% | 493,700 | +16.0% | 2.26% | +39.8% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $49,359,000 | +208.3% | 523,261 | +161.6% | 2.23% | +256.2% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $46,351,000 | +242.8% | 1,527,209 | +170.3% | 2.09% | +295.8% |
| GNMK | Buy | GENMARK DIAGNOSTICS INC | $36,608,000 | +0.2% | 5,640,748 | +9.5% | 1.65% | +15.9% |
| HHR | New | HEADHUNTER GROUP PLCsponsored ads | $14,788,000 | – | 910,000 | +100.0% | 0.67% | – |
| CVS | New | CVS HEALTH CORP | $10,898,000 | – | 200,000 | +100.0% | 0.49% | – |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $7,488,000 | +175.3% | 600,000 | +200.0% | 0.34% | +218.9% |
| GTTN | Buy | GTT COMMUNICATIONS INC | $6,160,000 | +778.7% | 350,000 | +1632.7% | 0.28% | +929.6% |
| LSXMK | Buy | LIBERTY MEDIA CORP DELAWARE | $5,638,000 | +66.7% | 148,459 | +67.8% | 0.25% | +92.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RADWARE LTD | 34 | Q3 2021 | 4.9% |
| PALO ALTO NETWORKS INC | 32 | Q3 2023 | 18.5% |
| PEGASYSTEMS INC | 27 | Q3 2023 | 9.1% |
| ALPHABET INC | 27 | Q3 2023 | 9.0% |
| GENMARK DIAGNOSTICS INC | 27 | Q1 2020 | 2.3% |
| VARONIS SYS INC | 26 | Q3 2023 | 9.5% |
| IAC INTERACTIVECORP | 24 | Q2 2020 | 17.8% |
| ELECTRONICS FOR IMAGING INC | 24 | Q1 2019 | 8.8% |
| ZOGENIX INC | 23 | Q4 2021 | 7.1% |
| NANOSTRING TECHNOLOGIES INC | 22 | Q2 2023 | 2.5% |
View CADIAN CAPITAL MANAGEMENT, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RADWARE LTDSold out | February 14, 2022 | 0 | 0.0% |
| TCV Acquisition Corp. | February 14, 2022 | 2,750,000 | 6.7% |
| WORLD WRESTLING ENTERTAINMENTINCSold out | February 14, 2022 | 0 | 0.0% |
| ZOGENIX, INC. | February 14, 2022 | 4,240,846 | 7.6% |
| GenMark Diagnostics, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NanoString Technologies IncSold out | February 12, 2021 | 0 | 0.0% |
| VARONIS SYSTEMS INC | February 12, 2021 | 1,017,422 | 3.2% |
| PORTOLA PHARMACEUTICALS INC | February 13, 2020 | 2,133,343 | 2.7% |
| ELECTRONICS FOR IMAGING INC | February 13, 2019 | 3,365,179 | 7.7% |
| trivago N.V.Sold out | February 13, 2019 | 0 | 0.0% |
View CADIAN CAPITAL MANAGEMENT, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View CADIAN CAPITAL MANAGEMENT, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.